Sign in
4

Changes in Ownership

Dogwood Therapeutics, Inc. Filed Acc 0001415889-21-006172

CHIEF EXECUTIVE OFFICER bought 5,000 shares at $5.52 ($27,615)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Duncan Gregory Scott CHIEF EXECUTIVE OFFICER 2021-12-21 Purchase +5,000 $5.52 $27,615 24,961 D
Open-market purchases · 5,000 sh · avg $5.52 · $27,615
Loading xslF345X03/form4-12222021_101249.xml…